Micro-Cap
Palisade Bio Reports Promising Results for UC Treatment PALI-2108
Successful Analysis Demonstrates Effective Bioactivation of Colon-Specific PDE4 Inhibitor Prodrug Palisade Bio (PALI), a biopharmaceutical firm dedicated to advancing therapies...
Kaival Brands Innovations Surges 250%: Trader Zack Morris’s Influence?
Trader Buzz and Market Momentum Propel Kaival Brands to New Heights Kaival Brands Innovations (KAVL), the exclusive U.S. distributor of...
PaxMedica Completes Milestone for Suramin IV Formulation, Nears FDA Submission
Biopharmaceutical Company Advances Potential Treatment for Fatal Tropical Disease and Autism Spectrum Disorder PaxMedica (PXMD) has achieved a significant milestone...
Rent the Runway Surpasses Expectations, Eyes Growth and Profitability in 2024
Innovations, Customer Retention Strategies Drive Positive Financial Performance Rent the Runway (RENT), the pioneering shared designer closet platform, exceeded revenue...
Candel Therapeutics’ CAN-2409 Receives FDA Orphan Drug Designation for Pancreatic Cancer
Milestone Achievement Enhances Development Efforts for Multimodal Biological Immunotherapy Candel Therapeutics (CADL) has achieved a significant milestone in its fight...
Advancing Addiction Treatment: Adial Pharmaceuticals’ AD04 Shows Promise in Clinical Study
Peer-Reviewed Article Highlights Safety and Efficacy of Low-Dose Ondansetron in Treating Alcohol Use Disorder Adial Pharmaceuticals (ADIL), a pioneer in...
Auddia’s AI Breakthrough: Revolutionizing Audio Experiences with Patented Technology
U.S. Patent Office Validates Auddia's Cutting-Edge AI Platform for Premium Audio Services Auddia (AUUD) has achieved a significant milestone with...
HUB Cyber Security Secures $8 Million Financing for Strategic Growth
Straight Debt Arrangement Strengthens Financial Foundation and Expansion Plans HUB Cyber Security Ltd. (HUBC) has announced a significant milestone with...
22nd Century Group Expands Manufacturing Portfolio with New Contract
Strategic Move Signals Growth and Commitment to Harm Reduction 22nd Century Group, Inc. (XXII) has unveiled a pivotal step in...
TC BioPharma Announces Strategic Expansion with NK Cell Therapeutics
Acquisition of CAR-NK Assets to Bolster Cancer Therapy Portfolio TC BioPharm (TCBP), a leading biotechnology company specializing in allogeneic gamma-delta...
